0001062993-23-013263.txt : 20230609
0001062993-23-013263.hdr.sgml : 20230609
20230609160756
ACCESSION NUMBER: 0001062993-23-013263
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230607
FILED AS OF DATE: 20230609
DATE AS OF CHANGE: 20230609
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kummeth Charles R.
CENTRAL INDEX KEY: 0001534980
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-17272
FILM NUMBER: 231005313
MAIL ADDRESS:
STREET 1: 425 MARTINGALE ROAD
STREET 2: SUITE 1000
CITY: SCHAUMBURG
STATE: IL
ZIP: 60173-2213
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIO-TECHNE Corp
CENTRAL INDEX KEY: 0000842023
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 411427402
STATE OF INCORPORATION: MN
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 614 MCKINLEY PL N E
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55413
BUSINESS PHONE: 6123798854
MAIL ADDRESS:
STREET 1: 614 MCKINLEY PLACE NE
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55413
FORMER COMPANY:
FORMER CONFORMED NAME: TECHNE CORP /MN/
DATE OF NAME CHANGE: 19920703
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0407
4
2023-06-07
0000842023
BIO-TECHNE Corp
TECH
0001534980
Kummeth Charles R.
614 MCKINLEY PLACE NE
MINNEAPOLIS
MN
55413
1
1
0
0
Chief Executive Officer
0
Common Stock
2023-06-07
4
S
0
322
83
D
1112817
D
Common Stock
400
I
By Step-Son
Common Stock
400
I
By Step-Daughter
Stock Options (Right to Buy)
26.65
2023-08-18
Common Stock
616676
616676
D
Stock Options (Right to Buy)
31.2625
2024-08-09
Common Stock
779084
779084
D
Stock Options (Right to Buy)
44.33
2025-08-08
Common Stock
361336
361336
D
Stock Options (Right to Buy)
44.33
2025-08-08
Common Stock
240888
240888
D
Stock Options (Right to Buy)
47.6025
2026-08-07
Common Stock
342900
342900
D
Restricted Stock Units
Common Stock
52900
52900
D
Stock Options (Right to Buy)
47.6025
2026-08-07
Common Stock
228600
228600
D
Restricted Stock Units
Common Stock
51516
51516
D
Stock Options (Right to Buy)
66.9675
2027-08-05
Common Stock
299768
299768
D
Stock Options (Right to Buy)
66.9675
2027-08-05
Common Stock
153180
153180
D
Stock Options (Right to Buy)
66.9675
2027-08-05
Common Stock
66600
66600
D
Stock Options (Right to Buy)
66.9675
2027-08-05
Common Stock
66600
66600
D
Restricted Stock Units
Common Stock
32064
32064
D
Stock Options (Right to Buy)
120.455
2028-08-06
Common Stock
125260
125260
D
Stock Options (Right to Buy)
120.455
2028-08-06
Common Stock
83504
83504
D
Stock Options (Right to Buy)
94.52
2029-08-15
Common Stock
1200000
1200000
D
Includes (i) 11,448 shares of restricted stock for which the risk of forfeiture will lapse on August 5, 2023; and (ii) 14,248 shares of restricted stock for which the risk of forfeiture will lapse as to 7,128 shares on each of August 6, 2023 and August 6, 2024.
Fully exercisable.
Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
17,632 shares vest on each of 8/15/2023 and 8/15/2025, and 17,636 shares vest on 8/15/2024.
Options to purchase 57,152 shares vest on each of 8/7/2020 and 8/7/2021 and options to purchase 57,148 shares vest on each of 8/7/2022 and 8/7/2023.
Vests in full or in part on 8/5/2023 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
Options to purchase 38,292 shares vest on 8/5/21 and options to purchase 38,296 shares vest on each of 8/5/22, 8/5/23 and 8/5/24.
Vests in full on the date performance of certain product revenue goals during the period of fiscal 2021-2023 is certified by the Administrator, in no event earlier than 8/5/2021.
Options to purchase 22,200 shares vest on each of 8/5/21, 8/5/22 and 8/5/23.
Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
Options to purchase 20,876 shares vest on each of 8/6/2022, 8/6/2023, 8/6/2024 and 8/6/2025.
600,000 options vest in full or in part on 7/1/2023 if certain performance goals are achieved (or such later date as performance is certified by the Administrator), and 600,000 options vest in full or in part on 7/1/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
/s/ Andrew Nick, as Attorney-in-Fact pursuant to Power of Attorney previously filed.
2023-06-09